345 related articles for article (PubMed ID: 23601082)
1. The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.
Marshall JL; Kwok Y; McMorran BJ; Baum LG; Crosbie-Watson RH
FEBS J; 2013 Sep; 280(17):4210-29. PubMed ID: 23601082
[TBL] [Abstract][Full Text] [Related]
2. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and α7 integrin.
Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2015 Apr; 24(7):2011-22. PubMed ID: 25504048
[TBL] [Abstract][Full Text] [Related]
3. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
[TBL] [Abstract][Full Text] [Related]
4. Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice.
Marshall JL; Chou E; Oh J; Kwok A; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2012 Oct; 21(20):4378-93. PubMed ID: 22798625
[TBL] [Abstract][Full Text] [Related]
5. Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2.
Mamsa H; Stark RL; Shin KM; Beedle AM; Crosbie RH
Hum Mol Genet; 2022 Mar; 31(5):718-732. PubMed ID: 34581784
[TBL] [Abstract][Full Text] [Related]
6. Sarcospan: a small protein with large potential for Duchenne muscular dystrophy.
Marshall JL; Crosbie-Watson RH
Skelet Muscle; 2013 Jan; 3(1):1. PubMed ID: 23282144
[TBL] [Abstract][Full Text] [Related]
7. Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice.
Peter AK; Miller G; Crosbie RH
J Cell Sci; 2007 Mar; 120(Pt 6):996-1008. PubMed ID: 17311848
[TBL] [Abstract][Full Text] [Related]
8. Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex.
Peter AK; Marshall JL; Crosbie RH
J Cell Biol; 2008 Nov; 183(3):419-27. PubMed ID: 18981229
[TBL] [Abstract][Full Text] [Related]
9. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice.
Araishi K; Sasaoka T; Imamura M; Noguchi S; Hama H; Wakabayashi E; Yoshida M; Hori T; Ozawa E
Hum Mol Genet; 1999 Sep; 8(9):1589-98. PubMed ID: 10441321
[TBL] [Abstract][Full Text] [Related]
10. Myogenic Akt signaling upregulates the utrophin-glycoprotein complex and promotes sarcolemma stability in muscular dystrophy.
Peter AK; Ko CY; Kim MH; Hsu N; Ouchi N; Rhie S; Izumiya Y; Zeng L; Walsh K; Crosbie RH
Hum Mol Genet; 2009 Jan; 18(2):318-27. PubMed ID: 18986978
[TBL] [Abstract][Full Text] [Related]
11. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex.
Crosbie RH; Heighway J; Venzke DP; Lee JC; Campbell KP
J Biol Chem; 1997 Dec; 272(50):31221-4. PubMed ID: 9395445
[TBL] [Abstract][Full Text] [Related]
12. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex.
Crosbie RH; Lebakken CS; Holt KH; Venzke DP; Straub V; Lee JC; Grady RM; Chamberlain JS; Sanes JR; Campbell KP
J Cell Biol; 1999 Apr; 145(1):153-65. PubMed ID: 10189375
[TBL] [Abstract][Full Text] [Related]
13. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
Matsumura K; Campbell KP
Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis of sarcospan overexpression in mdx skeletal muscle reveals compensatory remodeling of cytoskeleton-matrix interactions that promote mechanotransduction pathways.
McCourt JL; Stearns-Reider KM; Mamsa H; Kannan P; Afsharinia MH; Shu C; Gibbs EM; Shin KM; Kurmangaliyev YZ; Schmitt LR; Hansen KC; Crosbie RH
Skelet Muscle; 2023 Jan; 13(1):1. PubMed ID: 36609344
[TBL] [Abstract][Full Text] [Related]
16. Myotendinous junction defects and reduced force transmission in mice that lack alpha7 integrin and utrophin.
Welser JV; Rooney JE; Cohen NC; Gurpur PB; Singer CA; Evans RA; Haines BA; Burkin DJ
Am J Pathol; 2009 Oct; 175(4):1545-54. PubMed ID: 19729483
[TBL] [Abstract][Full Text] [Related]
17. Role of dystrophin isoforms and associated proteins in muscular dystrophy (review).
Culligan KG; Mackey AJ; Finn DM; Maguire PB; Ohlendieck K
Int J Mol Med; 1998 Dec; 2(6):639-48. PubMed ID: 9850730
[TBL] [Abstract][Full Text] [Related]
18. Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
Parvatiyar MS; Marshall JL; Nguyen RT; Jordan MC; Richardson VA; Roos KP; Crosbie-Watson RH
J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702077
[TBL] [Abstract][Full Text] [Related]
19. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle.
Crosbie RH; Barresi R; Campbell KP
FASEB J; 2002 Nov; 16(13):1786-91. PubMed ID: 12409321
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
